{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:16:01Z","timestamp":1791400561467,"version":"4.3.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,12,2]],"date-time":"2014-12-02T00:00:00Z","timestamp":1417478400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1038\/bjc.2014.602","type":"journal-article","created":{"date-parts":[[2014,12,2]],"date-time":"2014-12-02T20:56:43Z","timestamp":1417553803000},"page":"306-312","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":87,"title":["Pharmacokinetics of concomitant cisplatin and paclitaxel administered by hyperthermic intraperitoneal chemotherapy to patients with peritoneal carcinomatosis from epithelial ovarian cancer"],"prefix":"10.1038","volume":"112","author":[{"given":"L","family":"Ansaloni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Coccolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Morosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Ballerini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Ceresoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Grosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Bertoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L M","family":"Busci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Lotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Cambria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Pisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Rossetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Frigerio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"D'Incalci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Zucchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,2]]},"reference":[{"key":"BFbjc2014602_CR1","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1097\/IGC.0b013e31824d836c","volume":"22","author":"L Ansaloni","year":"2012","unstructured":"Ansaloni L, Agnoletti V, Amadori A, Catena F, Cavaliere D, Coccolini F, De Iaco P, Di Battista M, Framarini M, Gazzotti F, Ghermandi C, Kopf B, Saponara M, Tauceri F, Vallicelli C, Verdecchia GM, Pinna AD (2012) Evaluation of extensive cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with advanced epithelial ovarian cancer. Int J Gynecol Cancer 22: 778\u2013785.","journal-title":"Int J Gynecol Cancer"},{"key":"BFbjc2014602_CR2","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1245\/s10434-012-2237-2","volume":"19","author":"D Baratti","year":"2012","unstructured":"Baratti D, Kusamura S, Cabras AD, Deraco M (2012) Cytoreductive surgery with selective versus complete parietal peritonectomy followed by hyperthermic intraperitoneal chemotherapy in patients with diffuse malignant peritoneal mesothelioma: a controlled study. Ann Surg Oncol 19: 1416\u20131424.","journal-title":"Ann Surg Oncol"},{"key":"BFbjc2014602_CR3","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/s00280-011-1574-3","volume":"68","author":"A Canta","year":"2011","unstructured":"Canta A, Chiorazzi A, Carozzi V, Meregalli C, Oggioni N, Sala B, Crippa L, Avezza F, Forestieri D, Rotella G, Zucchetti M, Cavaletti G (2011) In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin). Cancer Chemother Pharmacol 68: 1001\u20131008.","journal-title":"Cancer Chemother Pharmacol"},{"key":"BFbjc2014602_CR4","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00228-012-1405-4","volume":"69","author":"PH Cashin","year":"2013","unstructured":"Cashin PH, Ehrsson H, Wallin I, Nygren P, Mahteme H (2013) Pharmacokinetics of cisplatin during hyperthermic intraperitoneal treatment of peritoneal carcinomatosis. Eur J Clin Pharmacol 69: 533\u2013540.","journal-title":"Eur J Clin Pharmacol"},{"key":"BFbjc2014602_CR5","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1093\/annonc\/mdr301","volume":"23","author":"PH Cashin","year":"2012","unstructured":"Cashin PH, Graf W, Nygren P, Mahteme H (2012) Intraoperative hyperthermic versus postoperative normothermic intraperitoneal chemotherapy for colonic peritoneal carcinomatosis: a case-control study. Ann Oncol 23: 647\u2013652.","journal-title":"Ann Oncol"},{"key":"BFbjc2014602_CR6","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1593\/neo.09866","volume":"11","author":"M Cesca","year":"2009","unstructured":"Cesca M, Frapolli R, Berndt A, Scarlato V, Richter P, Kosmehl H, D'Incalci M, Ryan AJ, Giavazzi R (2009) The effects of vandetanib on paclitaxel tumor distribution and antitumor activity in a xenograft model of human ovarian carcinoma. Neoplasia 11: 1155\u20131164.","journal-title":"Neoplasia"},{"key":"BFbjc2014602_CR7","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1177\/00912709922007967","volume":"39","author":"HK Cho","year":"1999","unstructured":"Cho HK, Lush RM, Bartlett DL, Alexander HR, Wu PC, Libutti SK, Lee KB, Venzon DJ, Bauer KS, Reed E, Figg WD (1999) Pharmacokinetics of cisplatin administered by continuous hyperthermic peritoneal perfusion (CHPP) to patients with peritoneal carcinomatosis. J Clin Pharmacol 39: 394\u2013401.","journal-title":"J Clin Pharmacol"},{"key":"BFbjc2014602_CR8","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s00384-011-1303-8","volume":"27","author":"TC Chua","year":"2012","unstructured":"Chua TC, Liauw W, Morris DL (2012) Early recurrence of pseudomyxoma peritonei following treatment failure of cytoreductive surgery and perioperative intraperitoneal chemotherapy is indicative of a poor survival outcome. Int J Colorectal Dis 27: 381\u2013389.","journal-title":"Int J Colorectal Dis"},{"key":"BFbjc2014602_CR9","doi-asserted-by":"publisher","first-page":"124","DOI":"10.5317\/wjog.v2.i4.124","volume":"2","author":"F Coccolini","year":"2013","unstructured":"Coccolini F, Ansaloni L, Corbella D, Lotti M, Glehen O (2013a) Criticalities in randomized controlled trials on HIPEC for ovarian cancer. World J Obstet Gynecol 2: 124\u2013128.","journal-title":"World J Obstet Gynecol"},{"key":"BFbjc2014602_CR10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ejso.2013.10.019","volume":"40","author":"F Coccolini","year":"2014","unstructured":"Coccolini F, Cotte E, Glehen O, Lotti M, Poiasina E, Catena F, Yonemura Y, Ansaloni L (2014) Intraperitoneal chemotherapy in advanced gastric cancer. Meta-analysis of randomized trials. Eur J Surg Oncol 40: 12\u201326.","journal-title":"Eur J Surg Oncol"},{"key":"BFbjc2014602_CR11","doi-asserted-by":"publisher","first-page":"6979","DOI":"10.3748\/wjg.v19.i41.6979","volume":"19","author":"F Coccolini","year":"2013","unstructured":"Coccolini F, Gheza F, Lotti M, Virzi S, Iusco D, Ghermandi C, Melotti R, Baiocchi G, Giulini SM, Ansaloni L, Catena F (2013b) Peritoneal carcinomatosis. World J Gastroenterol 19: 6979\u20136994.","journal-title":"World J Gastroenterol"},{"key":"BFbjc2014602_CR12","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1245\/s10434-007-9792-y","volume":"15","author":"E de Bree","year":"2008","unstructured":"de Bree E, Rosing H, Filis D, Romanos J, Melisssourgaki M, Daskalakis M, Pilatou M, Sanidas E, Taflampas P, Kalbakis K, Beijnen JH, Tsiftsis DD (2008) Cytoreductive surgery and intraoperative hyperthermic intraperitoneal chemotherapy with paclitaxel: a clinical and pharmacokinetic study. Ann Surg Oncol 15: 1183\u20131192.","journal-title":"Ann Surg Oncol"},{"key":"BFbjc2014602_CR13","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1245\/s10434-006-9167-9","volume":"14","author":"D Elias","year":"2007","unstructured":"Elias D, Benizri E, Di Pietrantonio D, Menegon P, Malka D, Raynard B (2007) Comparison of two kinds of intraperitoneal chemotherapy following complete cytoreductive surgery of colorectal peritoneal carcinomatosis. Ann Surg Oncol 14: 509\u2013514.","journal-title":"Ann Surg Oncol"},{"key":"BFbjc2014602_CR14","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s00280-005-0160-y","volume":"58","author":"R Fruscio","year":"2006","unstructured":"Fruscio R, Lissoni AA, Frapolli R, Corso S, Mangioni C, D'Incalci M, Zucchetti M (2006) Clindamycin-paclitaxel pharmacokinetic interaction in ovarian cancer patients. Cancer Chemother Pharmacol 58: 319\u2013325.","journal-title":"Cancer Chemother Pharmacol"},{"key":"BFbjc2014602_CR15","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/jso.21072","volume":"98","author":"S Gonzalez-Moreno","year":"2008","unstructured":"Gonzalez-Moreno S, Kusamura S, Baratti D, Deraco M (2008) Postoperative residual disease evaluation in the locoregional treatment of peritoneal surface malignancy. J Surg Oncol 98: 237\u2013241.","journal-title":"J Surg Oncol"},{"key":"BFbjc2014602_CR16","first-page":"2186","volume":"54","author":"SK Huang","year":"1994","unstructured":"Huang SK, Stauffer PR, Hong K, Guo JW, Phillips TL, Huang A, Papahadjopoulos D (1994) Liposomes and hyperthermia in mice: increased tumor uptake and therapeutic efficacy of doxorubicin in sterically stabilized liposomes. Cancer Res 54: 2186\u20132191.","journal-title":"Cancer Res"},{"key":"BFbjc2014602_CR17","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/j.1349-7006.2010.01747.x","volume":"102","author":"T Kamei","year":"2011","unstructured":"Kamei T, Kitayama J, Yamaguchi H, Soma D, Emoto S, Konno T, Ishihara K, Ishigami H, Kaisaki S, Nagawa H (2011) Spatial distribution of intraperitoneally administrated paclitaxel nanoparticles solubilized with poly (2-methacryloxyethyl phosphorylcholine-co n-butyl methacrylate) in peritoneal metastatic nodules. Cancer Sci 102: 200\u2013205.","journal-title":"Cancer Sci"},{"key":"BFbjc2014602_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF00296245","volume":"19","author":"DJ Kerr","year":"1987","unstructured":"Kerr DJ, Kaye SB (1987) Aspects of cytotoxic drug penetration, with particular reference to anthracyclines. Cancer Chemother Pharmacol 19: 1\u20135.","journal-title":"Cancer Chemother Pharmacol"},{"key":"BFbjc2014602_CR19","first-page":"3380","volume":"49","author":"G Los","year":"1989","unstructured":"Los G, Mutsaers PH, van der Vijgh WJ, Baldew GS, de Graaf PW, McVie JG (1989) Direct diffusion of cis-diamminedichloroplatinum(II) in intraperitoneal rat tumors after intraperitoneal chemotherapy: a comparison with systemic chemotherapy. Cancer Res 49: 3380\u20133384.","journal-title":"Cancer Res"},{"key":"BFbjc2014602_CR20","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/BF00685503","volume":"28","author":"G Los","year":"1991","unstructured":"Los G, Verdegaal EM, Mutsaers PH, McVie JG (1991) Penetration of carboplatin and cisplatin into rat peritoneal tumor nodules after intraperitoneal chemotherapy. Cancer Chemother Pharmacol 28: 159\u2013165.","journal-title":"Cancer Chemother Pharmacol"},{"key":"BFbjc2014602_CR21","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ejca.2005.06.030","volume":"42","author":"S Mielke","year":"2006","unstructured":"Mielke S, Sparreboom A, Mross K (2006) Peripheral neuropathy: a persisting challenge in paclitaxel-based regimes. Eur J Cancer 42: 24\u201330.","journal-title":"Eur J Cancer"},{"key":"BFbjc2014602_CR22","doi-asserted-by":"publisher","first-page":"e72532","DOI":"10.1371\/journal.pone.0072532","volume":"8","author":"L Morosi","year":"2013","unstructured":"Morosi L, Spinelli P, Zucchetti M, Pretto F, Carra A, D'Incalci M, Giavazzi R, Davoli E (2013) Determination of paclitaxel distribution in solid tumors by nano-particle assisted laser desorption ionization mass spectrometry imaging. PLoS One 8: e72532.","journal-title":"PLoS One"},{"key":"BFbjc2014602_CR23","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s002800050548","volume":"39","author":"N Nagai","year":"1996","unstructured":"Nagai N, Kinoshita M, Ogata H, Tsujino D, Wada Y, Someya K, Ohno T, Masuhara K, Tanaka Y, Kato K, Nagai H, Yokoyama A, Kurita Y (1996) Relationship between pharmacokinetics of unchanged cisplatin and nephrotoxicity after intravenous infusions of cisplatin to cancer patients. Cancer Chemother Pharmacol 39: 131\u2013137.","journal-title":"Cancer Chemother Pharmacol"},{"key":"BFbjc2014602_CR24","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1097\/01.cad.0000176505.94175.d4","volume":"16","author":"B Royer","year":"2005","unstructured":"Royer B, Guardiola E, Polycarpe E, Hoizey G, Delroeux D, Combe M, Chaigneau L, Samain E, Chauffert B, Heyd B, Kantelip JP, Pivot X (2005) Serum and intraperitoneal pharmacokinetics of cisplatin within intraoperative intraperitoneal chemotherapy: influence of protein binding. Anticancer Drugs 16: 1009\u20131016.","journal-title":"Anticancer Drugs"},{"key":"BFbjc2014602_CR25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/GCO.0b013e32831f8f32","volume":"21","author":"PH Sugarbaker","year":"2009","unstructured":"Sugarbaker PH (2009) Cytoreductive surgery and perioperative intraperitoneal chemotherapy for the treatment of advanced primary and recurrent ovarian cancer. Curr Opin Obstet Gynecol 21: 15\u201324.","journal-title":"Curr Opin Obstet Gynecol"},{"key":"BFbjc2014602_CR26","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/ijc.26340","volume":"131","author":"S Uboldi","year":"2012","unstructured":"Uboldi S, Bernasconi S, Romano M, Marchini S, Fuso Nerini I, Damia G, Ganzinelli M, Marangon E, Sala F, Clivio L, Chiorino G, Di Giandomenico S, Rocchi M, Capozzi O, Margison GsP, Watson AJ, Caccuri AM, Pastore A, Fossati A, Mantovani R, Grosso F, Tercero JC, Erba E, D'Incalci M (2012) Characterization of a new trabectedin-resistant myxoid liposarcoma cell line that shows collateral sensitivity to methylating agents. Int J Cancer 131: 59\u201369.","journal-title":"Int J Cancer"},{"key":"BFbjc2014602_CR27","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1080\/026567399285765","volume":"15","author":"M Urano","year":"1999","unstructured":"Urano M, Kuroda M, Nishimura Y (1999) For the clinical application of thermochemotherapy given at mild temperatures. Int J Hyperthermia 15: 79\u2013107.","journal-title":"Int J Hyperthermia"},{"key":"BFbjc2014602_CR28","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.soc.2012.07.013","volume":"21","author":"K Van der Speeten","year":"2012","unstructured":"Van der Speeten K, Stuart OA, Sugarbaker PH (2012) Pharmacology of perioperative intraperitoneal and intravenous chemotherapy in patients with peritoneal surface malignancy. Surg Oncol Clin N Am 21: 577\u2013597.","journal-title":"Surg Oncol Clin N Am"},{"key":"BFbjc2014602_CR29","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1245\/s10434-008-9966-2","volume":"15","author":"VJ Verwaal","year":"2008","unstructured":"Verwaal VJ, Bruin S, Boot H, van Slooten G, van Tinteren H (2008) 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol 15: 2426\u20132432.","journal-title":"Ann Surg Oncol"},{"key":"BFbjc2014602_CR30","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/0952-8180(92)90111-D","volume":"4","author":"Y Wang","year":"1992","unstructured":"Wang Y, Moss J, Thisted R (1992) Predictors of body surface area. J Clin Anesth 4: 4\u201310.","journal-title":"J Clin Anesth"},{"key":"BFbjc2014602_CR31","first-page":"2486","volume":"47","author":"PH Wiernik","year":"1987","unstructured":"Wiernik PH, Schwartz EL, Strauman JJ, Dutcher JP, Lipton RB, Paietta E (1987) Phase I clinical and pharmacokinetic study of taxol. Cancer Res 47: 2486\u20132493.","journal-title":"Cancer Res"},{"key":"BFbjc2014602_CR32","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1053\/ctrv.2001.0232","volume":"27","author":"AJ Witkamp","year":"2001","unstructured":"Witkamp AJ, de Bree E, Van Goethem R, Zoetmulder FA (2001) Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy. Cancer Treat Rev 27: 365\u2013374.","journal-title":"Cancer Treat Rev"},{"key":"BFbjc2014602_CR33","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1245\/s10434-011-1631-5","volume":"18","author":"XJ Yang","year":"2011","unstructured":"Yang XJ, Huang CQ, Suo T, Mei LJ, Yang GL, Cheng FL, Zhou YF, Xiong B, Yonemura Y, Li Y (2011) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial. Ann Surg Oncol 18: 1575\u20131581.","journal-title":"Ann Surg Oncol"},{"key":"BFbjc2014602_CR34","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/ijc.29011","volume":"136","author":"O Zivanovic","year":"2014","unstructured":"Zivanovic O, Abramian A, Kullmann M, Fuhrmann C, Coch C, Hoeller T, Ruehs H, Keyver-Paik MD, Rudlowski C, Weber S, Kiefer N, Poelcher ML, Thiesler T, Rostamzadeh B, Mallmann M, Schaefer N, Permantier M, Latten S, Kalff J, Thomale J, Jaehde U, Kuhn WC (2014) HIPEC ROC I: A phase i study of cisplatin administered as hyperthermic intraoperative intraperitoneal chemoperfusion followed by postoperative intravenous platinum-based chemotherapy in patients with platinum-sensitive recurrent epithelial ovarian cancer. Int J Cancer 136: 699\u2013708.","journal-title":"Int J Cancer"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bjc2014602.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2014602","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc2014602.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T15:04:03Z","timestamp":1717599843000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bjc2014602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["BFbjc2014602"],"URL":"https:\/\/doi.org\/10.1038\/bjc.2014.602","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,2]]},"assertion":[{"value":"31 July 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}